| HOME >> MEDICINE >> TECHNOLOGY |
Bristol-Myers Squibb Acquires Medarex II-34
Sanofi Pasteur Signs Licensing Agreement with Syntiron II-34
Sanofi Pasteur Inks Strategic Agreement with ShanH II-34
Access Pharmaceuticals Acquires Somanta Pharmaceuticals II-34
IMUC Completes Molecular Antibody Technology Acquisition II-35
Callisto Merger Corporation Merges with Celldex Therapeutics II-35
Arana and Kyowa Hakko Sign Agreement to Jointly Develop ART 104 II-35
Eusa Sells Antibody Research Business II-36
Dyax and Sanofi-Aventis Sign Agreements II-36
HGS Enters into Antibody Collaboration Agreement with Xencor II-37
Wyeth Pharmaceuticals and Biovitrum Extend ReFacto Supply
Agreement II-37
Caprotec Bioanalytics and Merck Ink Collaboration Agreement II-37
Biomonitor Snaps Up Neutekbio II-38
GE Healthcare Takes Over MicroCal II-38
Arana Therapeutics Enters into Collaboration with Greenovation
Biotech II-38
Bayer Healthcare Acquires Hemophilia Program Assets of Maxygen II-39
Sanofi Pasteur Holding Purchases Acambis II-39
GlaxoSmithKline Enters into Strategic Alliance with Archemix II-39
Talecris Biotherapeutics Inks License Agreement with Crucell II-40
Polyphor Signs Exclusive Licensing Agreement with Allergan II-40
Morphotek® Enters into Partnership with Pivotal BioSciences II-40
PharmAthene Snaps Up Biodefence Vaccines Business of Avercia
Biologics II-40
Raven Biotechnologies and CMC ICOS Biologics Ink an Agreement II-41
MacroGenics Purchases Raven Biotechnologies II-41
5. FOCUS ON SELECT PLAYERS II-42
Abbott Laboratories, Inc. (US) II-42
Alexion Pharmaceuticals, Inc. (US) II-42
Amgen, Inc. (US) II-42
Biogen Idec (US) II-43
Bristol-Myers Squibb Company (US) II-43
Medarex, Inc. (US) II-44
Crucell N.V. (The Nether
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |